Related Experiment Videos
Purification, crystallization and preliminary X-ray analysis of murine interleukin-5
1Department of Medical Microbiology and Infectious Diseases, University of Alberta, Edmonton, Canada.
Abstract:
Wild-type and mutant forms of murine interleukin-5 (mIL-5) have been expressed in the baculovirus expression system, purified, and used in crystallization trials. Attempts to obtain diffraction quality crystals of wild-type protein were unsuccessful. The substitution of glutamine for Asn75 preserved biological activity, while removing one of two predicted N-linked glycosylation sites, and the resulting protein was crystallized from polyethylene glycol 8000 at pH 7.8 in two crystal forms. The orthorhombic crystals, which belong to space group P2(1)2(1)2 with cell dimensions a = 55.9 A, b = 83.0 A and c = 52.3 A, diffract to beyond 2.5 A resolution. The second crystal form belongs to a trigonal space group, either P3(1)21 or P3(2)21, with cell dimensions a = b = 62.1 A, c = 129.9 A, and diffracts to about 3.8 A resolution. Each crystal form probably contains one mIL-5 dimer per asymmetric unit.
Insights
Researchers crystallized a mutant murine interleukin-5 (mIL-5) protein, essential for immune cell development. This structural insight aids in understanding mIL-5 function and developing targeted therapies.
Area of Science:
- Structural Biology
- Protein Crystallography
- Immunology
Background:
- Murine interleukin-5 (mIL-5) is crucial for eosinophil and basophil development.
- Understanding mIL-5 structure is key to its biological function and therapeutic potential.
- Wild-type mIL-5 crystallization proved challenging.
Purpose of the Study:
- To obtain diffraction-quality crystals of a modified murine interleukin-5 (mIL-5) protein.
- To facilitate structural determination of mIL-5 for functional and therapeutic studies.
Main Methods:
- Expression of wild-type and mutant murine interleukin-5 (mIL-5) using the baculovirus system.
- Purification of recombinant mIL-5.
- Crystallization trials of a mutant mIL-5 (Asn75Gln) using polyethylene glycol 8000.
- X-ray diffraction analysis of obtained crystal forms.
Main Results:
- Wild-type mIL-5 did not yield diffraction-quality crystals.
- A mutant mIL-5 (Asn75Gln) was successfully crystallized in two forms: orthorhombic (P2(1)2(1)2) and trigonal (P3(1)21 or P3(2)21).
- The orthorhombic crystals diffracted beyond 2.5 Å, and the trigonal crystals diffracted to approximately 3.8 Å.
Conclusions:
- The Asn75Gln mutation in mIL-5 preserves biological activity while enabling crystallization.
- Two distinct crystal forms of mIL-5 were obtained, providing structural data.
- These crystal structures will aid in understanding mIL-5 dimerization and receptor interactions.